Clinical Trials in Oncology West Coast

Amy Raymond

Executive Director, Therapeutic Strategy Lead, Rare Disease & Cellular and Genetic Medicines

Dr. Raymond has been a drug discovery and development professional for 20+ years, including progressive roles in rare disease clinical operations and rare disease clinical strategy. Her clinical development experience spans all therapeutic areas and all stages of the clinical development lifecycle, from Natural History studies through in-patient Phase I trials, and Long-Term Follow Up and Post Marketing surveillances.